School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Robert Schnepp

  • Department of Pediatrics
    Adjunct Assistant Professor
  • robert.schnepp@emory.edu
  • Schnepp Laboratory
  • Children's Healthcare of Atlanta
  • Aflac Cancer and Blood Disorders Center
    Pediatrics
    1760 Haygood Drive
Head shot of Robert Schnepp

Academic Appointment

  • Assistant Professor of Pediatrics, Emory University, Atlanta

Education

Degrees

  • MD, PhD from University of Pennsylvania
  • BS from La Salle University

Research

Publications

  • Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
    J Clin Oncol Volume: 43 Page(s): 2515 - 2526
    08/01/2025 Authors: Stein MN; Vinceneux A; Robbrecht D; Doger B; Autio KA; Schweizer MT; Calvo E; Medina L; Van Dongen M; Deville J-L
  • Intracranial and systemic progression on amivantamab in platinum-treated epidermal growth factor receptor exon 20 insertion-mutated advanced non-small cell lung cancer.
    Lung Cancer Volume: 205 Page(s): 108579
    07/01/2025 Authors: Leighl NB; Trigo J; Park K; Lee S-H; Girard N; Viteri S; Garrido P; Krebs MG; Thayu M; Knoblauch RE
  • The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.
    Mol Oncol Volume: 17 Page(s): 1784 - 1802
    09/01/2023 Authors: Shahab SW; Roggeveen CM; Sun J; Kunhiraman H; McSwain LF; Juraschka K; Kumar SA; Saulnier O; Taylor MD; Schniederjan M
  • Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma.
    Cell Rep Med Volume: 4 Page(s): 101091
    06/20/2023 Authors: Lee JY; Jonus HC; Sadanand A; Branella GM; Maximov V; Suttapitugsakul S; Schniederjan MJ; Shim J; Ho A; Parwani KK
  • Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target.
    Mol Oncol Volume: 15 Page(s): 2156 - 2171
    08/01/2021 Authors: Shields CE; Potlapalli S; Cuya-Smith SM; Chappell SK; Chen D; Martinez D; Pogoriler J; Rathi KS; Patel SA; Oristian KM
  • TARGETING THE RNA-BINDING PROTEIN LIN28B IN GROUP 3 MEDULLOBLASTOMA
    Volume: 23 Page(s): 8 - 8
    06/01/2021 Authors: Shahab S; Schnepp R; MacDonald T; Kenney A
  • YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma.
    Cancer Res Volume: 80 Page(s): 4741 - 4753
    11/01/2020 Authors: Shim J; Lee JY; Jonus HC; Arnold A; Schnepp RW; Janssen KM; Maximov V; Goldsmith KC
  • BMI1 constitutes a novel therapeutic vulnerability in fusion-positive rhabdomyosarcoma
    Volume: 80 Page(s): 67 - 68
    07/01/2020 Authors: Shields CE; Cuya SM; Chappell S; Rathi K; Patel S; Potlapalli S; Schnepp RW
  • A LIN28B-PDZ kinase axis promotes neuroblastoma metastasis
    Volume: 80 Page(s): 104 - 104
    07/01/2020 Authors: Chen D; Cox J; Annam J; Weingart M; Essien G; Rathi K; Khurana P; Cuya S; Harenza JL; Bosse K
  • RNA Binding Protein LIN28B: a prime time player shaping neuroblastoma aggression and metastasis.
    Oncoscience Volume: 7 Page(s): 52 - 56
    07/01/2020 Authors: Chen D; Schnepp RW
  • Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.
    Pediatr Blood Cancer Volume: 67 Page(s): e28267
    06/01/2020 Authors: Healy JR; Hart LS; Shazad AL; Gagliardi ME; Tsang M; Elias J; Ruden J; Farrel A; Rokita JL; Li Y
  • BMI1 IS A THERAPEUTIC TARGET IN RHABDOMYOSARCOMA
    Volume: 67 Page(s): S124 - S124
    06/01/2020 Authors: Shields C; Cuya S; Potlapalli S; Chappell S; Chen J; Rathi K; Patel S; Schnepp R
  • MSI2 IS A NOVEL ONCOGENIC DRIVER IN NEUROBLASTOMA
    Volume: 67 Page(s): S118 - S118
    06/01/2020 Authors: Pilgrim A; Cuya S; Chen D; Rokita JL; Rathi K; Li D; Mukarram M; Schnepp R
  • LIN28B-PDZ BINDING KINASE SIGNALING PROMOTES NEUROBLASTOMA METASTASIS
    Volume: 67 Page(s): S148 - S149
    06/01/2020 Authors: Chen J; Cox J; Annam J; Weingart M; Essien G; Rathi K; Rokita JL; Khurana P; Cuya S; Pilgrim A
  • LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.
    Neoplasia Volume: 22 Page(s): 231 - 241
    04/24/2020 Authors: Chen D; Cox J; Annam J; Weingart M; Essien G; Rathi KS; Rokita JL; Khurana P; Cuya SM; Bosse KR
  • Targeting epigenetic regulator BMI-1 in alveolar rhabdomyosarcoma
    Volume: 79
    07/01/2019 Authors: Shields CE; Cuya SM; Chappell SK; Rathi K; Patel S; Potlapalli S; Schnepp RW
  • Defining an ELAVL1-Musashi 2 signaling cascade in neuroblastoma tumorigenesis
    Volume: 79
    07/01/2019 Authors: Cuya SM; Pilgrim A; Rathi K; Chen D; Schnepp R
  • Defining the role of the RNA-binding protein MSI2 in neuroblastoma
    Volume: 79
    07/01/2019 Authors: Pilgrim A; Cuya S; Chen D; Schnepp R
  • A LIN28B-PBK Axis promotes neuroblastoma dissemination and aggression
    Volume: 79
    07/01/2019 Authors: Chen D; Cox J; Annam J; Weingart M; Essien G; Rathi K; Khurana P; Cuya SM; Schnepp RW
  • Antitumor activity and sensitivity evaluation of novel BET inhibitors in neuroblastoma
    Volume: 14
    11/01/2016 Authors: Healy JR; Schnepp RW; Hart LS; Raman P; Danielson L; Russell M; Khurana P; Gagliardi M; Kinsey RM; Wyce A
  • LIN28B: an orchestrator of oncogenic signaling in neuroblastoma.
    Cell Cycle Volume: 15 Page(s): 772 - 774
    01/01/2016 Authors: Schnepp RW; Diskin SJ
  • A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.
    Cancer Cell Volume: 28 Page(s): 599 - 609
    11/09/2015 Authors: Schnepp RW; Khurana P; Attiyeh EF; Raman P; Chodosh SE; Oldridge DA; Gagliardi ME; Conkrite KL; Asgharzadeh S; Seeger RC
  • Antitumor activity and sensitivity evaluation of novel BET inhibitors in neuroblastoma
    Volume: 13
    10/01/2015 Authors: Healy JR; Schnepp RW; Hart LS; Raman P; Danielson L; Russell M; Khurana P; Gagliardi M; Kinsey RM; Wyce A
  • Improving Patient Outcomes With Cancer Genomics: Unique Opportunities and Challenges in Pediatric Oncology.
    JAMA Volume: 314 Page(s): 881 - 883
    09/01/2015 Authors: Schnepp RW; Bosse KR; Maris JM
  • A LIN28B/RAN/AURKA signaling network promotes neuroblastoma tumorigenesis
    Volume: 75
    08/01/2015 Authors: Schnepp RW; Khurana P; Attiyeh EF; Chodosn S; Raman P; Oldridge DA; Gagliardi ME; Conkrite K; Asgharzadeh S; Seeger RC
  • Defining the antitumor activity and sensitivity profiles of BET inhibitors in neuroblastoma
    CANCER RESEARCH Volume: 74
    10/01/2014 Authors: Schnepp R; Hart L; Raman P; Danielson L; Gagliardi M; Kinsey R; Wyce A; Barbash O; Tummino P; Chesler L
  • Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.
    Clin Cancer Res Volume: 19 Page(s): 6173 - 6182
    11/15/2013 Authors: Rader J; Russell MR; Hart LS; Nakazawa MS; Belcastro LT; Martinez D; Li Y; Carpenter EL; Attiyeh EF; Diskin SJ
  • The role of LIN28B and RAN in promoting neuroblastoma tumorigenesis
    Volume: 73
    04/15/2013 Authors: Schnepp RW; Attiyeh EF; Gagliardi ME; Chodosh S; Maris JM; Diskin SJ
  • CDK4/CDK6 inhibition is potently active in a definable subset of human neuroblastomas.
    Volume: 73
    04/15/2013 Authors: Rader J; Hart L; Russell M; Nakazawa M; Belcastro L; Martinez D; Carpenter E; Kim S; Parasuraman S; Caponigro G
  • Targeting MYCN: a good BET for improving neuroblastoma therapy?
    Cancer Discov Volume: 3 Page(s): 255 - 257
    03/01/2013 Authors: Schnepp RW; Maris JM
  • Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
    Nat Genet Volume: 44 Page(s): 1126 - 1130
    10/01/2012 Authors: Diskin SJ; Capasso M; Schnepp RW; Cole KA; Attiyeh EF; Hou C; Diamond M; Carpenter EL; Winter C; Lee H
  • New neuroblastoma susceptibility loci at 6q21 within HACE1 and LIN28B
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Diskin SJ; Capasso M; Latorre V; Schnepp R; Attiyeh EF; Diamond M; Hou C; Carpenter EL; Lee H; Cole KA
  • Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.
    Cancer Res Volume: 72 Page(s): 2068 - 2078
    04/15/2012 Authors: Bosse KR; Diskin SJ; Cole KA; Wood AC; Schnepp RW; Norris G; Nguyen LB; Jagannathan J; Laquaglia M; Winter C
  • GERMLINE VARIATIONS ARE ASSOCIATED WITH SUSCEPTIBILITY TO HIGH-RISK NEUROBLASTOMA AND IDENTIFY PATHWAYS WITH GAIN OF FUNCTION
    PEDIATRIC BLOOD & CANCER Volume: 57 Page(s): 724 - 724
    11/01/2011 Authors: Wood A; Bosse K; Wang K; Diskin S; Schnepp R; Diamond M; Attiyeh E; Morozova O; Pugh T; Mosse Y
  • Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
    Nature Volume: 469 Page(s): 216 - 220
    01/13/2011 Authors: Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA
  • Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.
    J Biol Chem Volume: 282 Page(s): 31332 - 31340
    10/26/2007 Authors: La P; Yang Y; Karnik SK; Silva AC; Schnepp RW; Kim SK; Hua X
  • Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression.
    Oncogene Volume: 25 Page(s): 3537 - 3546
    06/15/2006 Authors: La P; Desmond A; Hou Z; Silva AC; Schnepp RW; Hua X
  • Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
    Cancer Res Volume: 66 Page(s): 5707 - 5715
    06/01/2006 Authors: Schnepp RW; Chen Y-X; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
  • Cardiorespiratory adjustments of homing pigeons to steady wind tunnel flight.
    J Exp Biol Volume: 208 Page(s): 3109 - 3120
    08/01/2005 Authors: Peters GW; Steiner DA; Rigoni JA; Mascilli AD; Schnepp RW; Thomas SP
  • Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
    Proc Natl Acad Sci U S A Volume: 102 Page(s): 749 - 754
    01/18/2005 Authors: Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D
  • Direct binding of DNA by tumor suppressor menin.
    J Biol Chem Volume: 279 Page(s): 49045 - 49054
    11/19/2004 Authors: La P; Silva AC; Hou Z; Wang H; Schnepp RW; Yan N; Shi Y; Hua X
  • Functional interaction between tumor suppressor menin and activator of S-phase kinase.
    Cancer Res Volume: 64 Page(s): 6791 - 6796
    09/15/2004 Authors: Schnepp RW; Hou Z; Wang H; Petersen C; Silva A; Masai H; Hua X
  • Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2.
    Endocrinology Volume: 145 Page(s): 3443 - 3450
    07/01/2004 Authors: La P; Schnepp RW; D Petersen C; C Silva A; Hua X
  • Menin induces apoptosis in murine embryonic fibroblasts
    Volume: 255 Page(s): 721 - 721
    06/01/2004 Authors: Schnepp RW; Mao H; Sykes SM; Zong WX; Silva A; La P; Hua X
  • Tumor-suppressor menin regulates expression of insulin-like growth factor-binding protein 2 (IGFBP-2)
    Volume: 255 Page(s): 722 - 722
    06/01/2004 Authors: La P; Schnepp RW; Petersen CD; Silva AC; Hua X
  • Menin induces apoptosis in murine embryonic fibroblasts.
    J Biol Chem Volume: 279 Page(s): 10685 - 10691
    03/12/2004 Authors: Schnepp RW; Mao H; Sykes SM; Zong W-X; Silva A; La P; Hua X
  • Menin associates with FANCD2, a protein involved in repair of DNA damage.
    Cancer Res Volume: 63 Page(s): 4204 - 4210
    07/15/2003 Authors: Jin S; Mao H; Schnepp RW; Sykes SM; Silva AC; D'Andrea AD; Hua X
  • Fusion proteins of retinoid receptors antagonize TGF-beta-induced growth inhibition of lung epithelial cells.
    Oncogene Volume: 22 Page(s): 198 - 210
    01/16/2003 Authors: La P; Morgan TA; Sykes SM; Mao H; Schnepp RW; Petersen CD; Hua X
  • A tumor-suppressing duo: TGFbeta and activin modulate a similar transcriptome.
    Cancer Biol Ther Volume: 2 Page(s): 171 - 172
    01/01/2003 Authors: Schnepp R; Hua X
  • Hop is an unusual homeobox gene that modulates cardiac development.
    Cell Volume: 110 Page(s): 713 - 723
    09/20/2002 Authors: Chen F; Kook H; Milewski R; Gitler AD; Lu MM; Li J; Nazarian R; Schnepp R; Jen K; Biben C
  • Analysis and knockout of Toto, a novel homeobox gene in early cardiac development
    Volume: 104 Page(s): 75 - 75
    10/23/2001 Authors: Chen F; Nazarian R; Milewski RC; Schnepp RW; Chi NC; Lu MM; Epstein JA
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements